Agilent Technologies (A) Common Equity (2009 - 2026)
Agilent Technologies' (A) quarterly Common Equity came in at $7.4 billion in Q3 2026, up 15.59% year-over-year from $6.4 billion in Q3 2025, and up 3.38% quarter-over-quarter from $7.1 billion in Q2 2026.
Analysis
Agilent Technologies (A) Common Equity (2009 - 2026) Analysis & Trends
Agilent Technologies (A) has reported Common Equity for 18 consecutive years, with $7.4 billion the latest figure, recorded in Q3 2026.
- On a quarterly basis, Common Equity rose 15.59% year-over-year to $7.4 billion in Q3 2026; TTM through Jul 2026 was $7.4 billion, a 15.59% increase from a year earlier, with the FY2025 full-year figure at $6.7 billion, up 14.29% from the prior year.
- Common Equity was $7.4 billion for Q3 2026 at Agilent Technologies, up from $7.1 billion in the prior quarter.
- Over five years, Common Equity peaked at $7.4 billion in Q3 2026 and troughed at -$327.0 million in Q4 2023.
- A 5-year average of $5.7 billion and a median of $5.9 billion in 2024 frame the typical range for Common Equity.
- Across the five-year window, Common Equity sank 106.16% in 2023 and jumped 1903.67% in 2024, its largest moves.
- Over 5 years, Common Equity stood at $5.3 billion in 2022, then slumped by 106.16% to -$327.0 million in 2023, then jumped by 1903.67% to $5.9 billion in 2024, then grew by 14.29% to $6.7 billion in 2025, then grew by 9.23% to $7.4 billion in 2026.
- The last three Common Equity figures came in at $7.4 billion (Q3 2026), $7.1 billion (Q2 2026), and $6.9 billion (Q1 2026), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 52.69 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 52.59 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 7.36 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 2.84 Bn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 7.23 Bn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 2.11 Bn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 7.17 Bn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 2.11 Bn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 825.55 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 2.40 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 7.36 Bn |
| Apr 30, 2026 | 7.12 Bn |
| Jan 31, 2026 | 6.91 Bn |
| Oct 31, 2025 | 6.74 Bn |
| Jul 31, 2025 | 6.37 Bn |
| Apr 30, 2025 | 6.14 Bn |
| Jan 31, 2025 | 6.03 Bn |
| Oct 31, 2024 | 5.90 Bn |
| Jul 31, 2024 | 5.90 Bn |
| Apr 30, 2024 | 6.21 Bn |
| Jan 31, 2024 | 6.19 Bn |
| Oct 31, 2023 | -327.00 Mn |
| Jul 31, 2023 | 5.56 Bn |
| Apr 30, 2023 | 5.78 Bn |
| Jan 31, 2023 | 5.61 Bn |
| Oct 31, 2022 | 5.31 Bn |
| Jul 31, 2022 | 5.09 Bn |
| Apr 30, 2022 | 5.12 Bn |
| Jan 31, 2022 | 5.15 Bn |
| Oct 31, 2021 | 5.39 Bn |